These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37847509)

  • 1. Delineating a Role for Methionine Metabolism in Colorectal Cancer.
    Liu S; Locasale JW
    Cancer Res; 2023 Dec; 83(23):3833-3834. PubMed ID: 37847509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary methionine influences therapy in mouse cancer models and alters human metabolism.
    Gao X; Sanderson SM; Dai Z; Reid MA; Cooper DE; Lu M; Richie JP; Ciccarella A; Calcagnotto A; Mikhael PG; Mentch SJ; Liu J; Ables G; Kirsch DG; Hsu DS; Nichenametla SN; Locasale JW
    Nature; 2019 Aug; 572(7769):397-401. PubMed ID: 31367041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Li Y; Wang C; Li D; Deng P; Shao X; Hu J; Liu C; Jie H; Lin Y; Li Z; Qian X; Zhang H; Zhao Y
    Oncol Rep; 2017 Nov; 38(5):3044-3054. PubMed ID: 28901465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The applications of metabolomics in the molecular diagnostics of cancer.
    Cheung PK; Ma MH; Tse HF; Yeung KF; Tsang HF; Chu MKM; Kan CM; Cho WCS; Ng LBW; Chan LWC; Wong SCC
    Expert Rev Mol Diagn; 2019 Sep; 19(9):785-793. PubMed ID: 31414918
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer.
    Shen Y; Sun M; Zhu J; Wei M; Li H; Zhao P; Wang J; Li R; Tian L; Tao Y; Shen P; Zhang J
    Mol Omics; 2021 Jun; 17(3):464-471. PubMed ID: 33881127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
    Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer.
    Fan X; Rao J; Zhang Z; Li D; Cui W; Zhang J; Wang H; Tou F; Zheng Z; Shen Q
    Cell Physiol Biochem; 2018; 46(4):1317-1330. PubMed ID: 29689551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in metabolomics in oncology.
    O'Connell TM
    Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinct metabolic signature of human colorectal cancer with prognostic potential.
    Qiu Y; Cai G; Zhou B; Li D; Zhao A; Xie G; Li H; Cai S; Xie D; Huang C; Ge W; Zhou Z; Xu LX; Jia W; Zheng S; Yen Y; Jia W
    Clin Cancer Res; 2014 Apr; 20(8):2136-46. PubMed ID: 24526730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
    Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
    Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage.
    Gu H; Zhang P; Zhu J; Raftery D
    Anal Chem; 2015 Dec; 87(24):12355-62. PubMed ID: 26579731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and quantitative evaluation of a high-resolution metabolomics technology.
    Liu X; Ser Z; Locasale JW
    Anal Chem; 2014 Feb; 86(4):2175-84. PubMed ID: 24410464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
    Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
    Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and Apoptotic Activity of Chamaecyparis obtusa Leaf Extract against the HCT116 Human Colorectal Cancer Cell Line and Investigation of the Bioactive Compound by Gas Chromatography-Mass Spectrometry-Based Metabolomics.
    Kim HY; Lee SG; Oh TJ; Lim SR; Kim SH; Lee HJ; Kim YS; Choi HK
    Molecules; 2015 Oct; 20(10):18066-82. PubMed ID: 26445036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.
    Martín-Blázquez A; Díaz C; González-Flores E; Franco-Rivas D; Jiménez-Luna C; Melguizo C; Prados J; Genilloud O; Vicente F; Caba O; Pérez Del Palacio J
    Sci Rep; 2019 Dec; 9(1):20198. PubMed ID: 31882610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics and detection of colorectal cancer in humans: a systematic review.
    Wang H; Tso VK; Slupsky CM; Fedorak RN
    Future Oncol; 2010 Sep; 6(9):1395-406. PubMed ID: 20919825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes.
    Mazi TA; Sarode GV; Czlonkowska A; Litwin T; Kim K; Shibata NM; Medici V
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans.
    Manna SK; Tanaka N; Krausz KW; Haznadar M; Xue X; Matsubara T; Bowman ED; Fearon ER; Harris CC; Shah YM; Gonzalez FJ
    Gastroenterology; 2014 May; 146(5):1313-24. PubMed ID: 24440673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.
    Zhang F; Zhang Y; Zhao W; Deng K; Wang Z; Yang C; Ma L; Openkova MS; Hou Y; Li K
    Oncotarget; 2017 May; 8(21):35460-35472. PubMed ID: 28389626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.